tiprankstipranks

BROKERAGE - New Portfolio

Bill T

BROKERAGE
Individual Investor
Ranked #156,572 out of 781,066 TipRanks' Investors
Success Rate
57%
880 out of 1551
profitable transactions
Average Return
19.00%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▲ 2.43%
6-Month Return▲ 8.39%
12-Month Return▲ 28.03%
YTD Return▲ 2.33%
Total Return▲ 52.84%

Best Trade

Opened at
Closed at
Gain▲ 1248.21%

Bio

Performance

26.04%0-26.04%
▲ 9.79%
▲ 3.53%
▲ 2.41%
Jun 2024
▲ 8.13%
▲ 1.21%
▲ 7.15%
Jul 2024
▼ 13.14%
▲ 2.34%
▲ 1.52%
Aug 2024
▲ 2.93%
▲ 2.10%
▲ 0.10%
Sep 2024
▲ 10.00%
▼ 0.89%
▼ 1.00%
Oct 2024
▲ 26.04%
▲ 5.96%
▲ 8.49%
Nov 2024
▲ 5.93%
▼ 2.41%
▼ 2.87%
Dec 2024
▲ 9.79%
▲ 0.95%
▲ 2.33%
Jan 2025
TipRanks AverageS&P 500Investor Portfolio
▲ 9.79%▲ 3.53%▲ 2.41%
▲ 8.13%▲ 1.21%▲ 7.15%
▼ 13.14%▲ 2.34%▲ 1.52%
▲ 2.93%▲ 2.10%▲ 0.10%
▲ 10.00%▼ 0.89%▼ 1.00%
▲ 26.04%▲ 5.96%▲ 8.49%
▲ 5.93%▼ 2.41%▼ 2.87%
▲ 9.79%▲ 0.95%▲ 2.33%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
Skyworks Solutions
0.34%
▲ 28.49%
21
Buy
Dec 24, 2024
Cirrus Logic
0.32%
▲ 29.60%
14
Sell
Dec 23, 2024
Qorvo
0.37%
▼ 6.48%
9
Buy
Dec 23, 2024
Lattice Semiconductor
0.33%
▼ 11.02%
15
Buy
Dec 23, 2024
Apple
0.64%
▲ 27.79%
24
Buy
Dec 23, 2024
Nvidia
1.39%
▲ 603.61%
24
Sell
Dec 23, 2024
Illumina
0.56%
▼ 30.72%
14
Sell
Dec 23, 2024
NXP Semiconductors
0.43%
▲ 19.71%
21
Sell
Dec 23, 2024
MannKind
8.65%
▼ 0.63%
49
Sell
Dec 23, 2024
iShares 20+ Year Treasury Bond ETF
19.45%
▼ 4.65%
33
Buy
Dec 23, 2024
Recursion Pharmaceuticals
1.55%
▼ 15.09%
14
Buy
Dec 23, 2024
SEI Institutional Managed Trust Tax-Managed Large Cap Fund Class F
22.06%
▲ 74.95%
12
Buy
Dec 19, 2024
Electronic Arts
0.49%
▼ 0.97%
14
Buy
Dec 18, 2024
Alphabet Class C
0.31%
▲ 18.16%
5
Buy
Dec 16, 2024
Arista Networks
1.39%
▲ 123.11%
3
Buy
Dec 04, 2024
Cognex
0.27%
▼ 45.96%
10
Buy
Nov 29, 2024
Accenture
0.38%
▲ 21.48%
10
Buy
Nov 19, 2024
Chase Packaging
▼ 74.70%
2
Close
Nov 19, 2024
ASML Holding
0.71%
▲ 44.12%
9
Buy
Nov 13, 2024
Bristol-Myers Squibb
0.6%
▼ 16.06%
23
Buy
Nov 01, 2024